Skip to main content
Future Journal of Pharmaceutical Sciences

Table 4 System suitability results of amivantamab

From: Bioanalytical method development and validation for quantification of amivantamab in rat plasma by LC-MS/MS

 

Name

Retention time

Area

USP tailing

Theoretical plate

USP resolution

1

Amivantamab

2.128

3265124

1.07

6594

 

2

Trastuzumab

4.136

4485769

1.01

7318

8.19

Back to article page